A Phase 1 Open-Label, Multicenter Study to Evaluate Biomarkers for ZN-c5 in Subjects with EstrogenReceptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.

  • Sabanathan, Dhanusha (Primary Chief Investigator)
  • Park, John (Associate Investigator)
  • Chapman, Nicola (Clinical Trial Unit Staff)

Project: Research

Project Details

AcronymZN-c5-002
StatusFinished
Effective start/end date15/10/20 → 23/07/21